Replies to post #232104 on Biotech Values

[DewDiligence]

RVNC caveat—It’s possible that ASPEN-OLS is fully enrolled because the FDA agreed to lower the target enrollment due to COVID-19. I just realized that Mark Foley’s language on today’s CC leaves enough wiggle room for the above interpretation.

[dewophile]

RVNC

It's a significant update but definitely a second order issue compared to the readout of the efficacy study.
Any mention on the call about Covid possibly impacting inspection of their manufacturing facility?

[DewDiligence]

RVNC—ASPEN-OLS open-label safety study in CD is fully enrolled with 354 patients (reduced from original goal due to COVID). Data from ASPEN-OLS will be reported in 2021. Source: Today’s CC.